RU2000123400A - METHOD FOR REMOVING ETHIOLOGICAL FACTOR (FACTORS) OF TRANSMISSIVE SPAN Encephalopathies FROM PROTEIN SOLUTIONS - Google Patents
METHOD FOR REMOVING ETHIOLOGICAL FACTOR (FACTORS) OF TRANSMISSIVE SPAN Encephalopathies FROM PROTEIN SOLUTIONSInfo
- Publication number
- RU2000123400A RU2000123400A RU2000123400/12A RU2000123400A RU2000123400A RU 2000123400 A RU2000123400 A RU 2000123400A RU 2000123400/12 A RU2000123400/12 A RU 2000123400/12A RU 2000123400 A RU2000123400 A RU 2000123400A RU 2000123400 A RU2000123400 A RU 2000123400A
- Authority
- RU
- Russia
- Prior art keywords
- adsorbent
- solution
- ncta
- paragraphs
- protein solution
- Prior art date
Links
- 239000012460 protein solution Substances 0.000 title claims 7
- 206010014623 Encephalopathy Diseases 0.000 title 1
- 239000003463 adsorbent Substances 0.000 claims 12
- 239000000243 solution Substances 0.000 claims 6
- 238000011109 contamination Methods 0.000 claims 4
- 239000010451 perlite Substances 0.000 claims 3
- 235000019362 perlite Nutrition 0.000 claims 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 3
- 239000005909 Kieselgur Substances 0.000 claims 2
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 claims 2
- 239000000440 bentonite Substances 0.000 claims 2
- 229910000278 bentonite Inorganic materials 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 229910052751 metal Inorganic materials 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 229910000000 metal hydroxide Inorganic materials 0.000 claims 2
- 150000004692 metal hydroxides Chemical class 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K Aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- 229940024545 Aluminum Hydroxide Drugs 0.000 claims 1
- 229940024546 Aluminum Hydroxide Gel Drugs 0.000 claims 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L Magnesium hydroxide Chemical group [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims 1
- 210000002381 Plasma Anatomy 0.000 claims 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N Silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims 1
- 229960005467 algeldrate Drugs 0.000 claims 1
- 238000005119 centrifugation Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002734 clay mineral Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 229920001059 synthetic polymer Polymers 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
Claims (15)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98810108.5 | 1998-02-11 | ||
EP98810108A EP0937735B1 (en) | 1998-02-11 | 1998-02-11 | A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2000123400A true RU2000123400A (en) | 2002-08-27 |
RU2204566C2 RU2204566C2 (en) | 2003-05-20 |
Family
ID=8235933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2000123400/12A RU2204566C2 (en) | 1998-02-11 | 1998-12-14 | Method for removal of etiological factor (factors) of transmissible spongy encephalopathy from protein solutions |
Country Status (17)
Country | Link |
---|---|
US (1) | US6407212B1 (en) |
EP (1) | EP0937735B1 (en) |
JP (1) | JP4259758B2 (en) |
CN (1) | CN1284963A (en) |
AT (1) | ATE233275T1 (en) |
AU (1) | AU742239B2 (en) |
CA (1) | CA2320190C (en) |
DE (1) | DE69811628T2 (en) |
DK (1) | DK0937735T3 (en) |
ES (1) | ES2193499T3 (en) |
HU (1) | HUP0100708A2 (en) |
NO (1) | NO20004029L (en) |
NZ (1) | NZ506055A (en) |
PL (1) | PL342002A1 (en) |
RU (1) | RU2204566C2 (en) |
SK (1) | SK11832000A3 (en) |
WO (1) | WO1999041274A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1144015E (en) * | 1999-01-19 | 2004-09-30 | Common Services Agency | TREATMENT OF LIQUIDS CONTAINING PROTEINS |
CA2435255A1 (en) * | 2001-01-16 | 2002-08-15 | Biotransplant, Inc. | Use of high density microparticles for removal of pathogens |
WO2002090379A1 (en) * | 2001-05-08 | 2002-11-14 | Serologicals Royalty Company | Process for inactivating prions in lipoproteins |
WO2005036125A2 (en) * | 2003-09-10 | 2005-04-21 | Triosyn Holding, Inc. | System, method and apparatus for purifying biological fluids such as blood and constituents thereof |
EP2734281A1 (en) * | 2011-07-20 | 2014-05-28 | Qiagen GmbH | Filtering devices comprising clay minerals |
US11638656B2 (en) | 2012-12-31 | 2023-05-02 | Xtreme Orthopedics Llc | Shoulder and arm restraint |
US10398585B2 (en) | 2013-05-30 | 2019-09-03 | Xtreme Orthopedics Llc | Shoulder and arm restraint |
USD962450S1 (en) | 2013-05-30 | 2022-08-30 | Extreme Orthopedics Llc | Shoulder immobilizer pillow |
DE102015210395A1 (en) | 2015-06-05 | 2016-12-08 | Technische Universität Dresden | Filter device and a method for the selective separation of an analyte from a liquid |
JP6664714B2 (en) * | 2016-05-09 | 2020-03-13 | 株式会社理研テクノシステム | Method for reducing infectivity of abnormal prion protein and pharmaceutical composition for prevention and treatment of prion disease |
CN107090026B (en) * | 2017-03-27 | 2021-06-25 | 武汉中原瑞德生物制品有限责任公司 | Method and system for separating plasma protein from blood product using diatomite |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2651437A1 (en) * | 1989-09-05 | 1991-03-08 | Lille Transfusion Sanguine | PROCESS FOR PREPARING A CONCENTRATE OF THE VON WILLEBRAND FACTOR VIII-FACTOR COMPLEX OF BLOOD COAGULATION FROM TOTAL PLASMA. |
EP0679405A1 (en) * | 1994-04-25 | 1995-11-02 | Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk | Method for separating viruses from protein solutions |
WO1997034642A1 (en) * | 1996-03-15 | 1997-09-25 | Pasteur Merieux Serums Et Vaccins | Method for removing unconventional transmissible agents from a protein solution |
US5808011A (en) * | 1996-07-01 | 1998-09-15 | Biopure Corporation | Method for chromatographic removal of prions |
US6221614B1 (en) * | 1997-02-21 | 2001-04-24 | The Regents Of The University Of California | Removal of prions from blood, plasma and other liquids |
-
1998
- 1998-02-11 AT AT98810108T patent/ATE233275T1/en active
- 1998-02-11 DK DK98810108T patent/DK0937735T3/en active
- 1998-02-11 DE DE69811628T patent/DE69811628T2/en not_active Expired - Lifetime
- 1998-02-11 ES ES98810108T patent/ES2193499T3/en not_active Expired - Lifetime
- 1998-02-11 EP EP98810108A patent/EP0937735B1/en not_active Expired - Lifetime
- 1998-12-14 NZ NZ506055A patent/NZ506055A/en not_active IP Right Cessation
- 1998-12-14 CN CN98813583A patent/CN1284963A/en active Pending
- 1998-12-14 AU AU22726/99A patent/AU742239B2/en not_active Ceased
- 1998-12-14 WO PCT/EP1998/008166 patent/WO1999041274A1/en not_active Application Discontinuation
- 1998-12-14 US US09/582,644 patent/US6407212B1/en not_active Expired - Lifetime
- 1998-12-14 PL PL98342002A patent/PL342002A1/en not_active Application Discontinuation
- 1998-12-14 RU RU2000123400/12A patent/RU2204566C2/en not_active IP Right Cessation
- 1998-12-14 HU HU0100708A patent/HUP0100708A2/en unknown
- 1998-12-14 JP JP2000531465A patent/JP4259758B2/en not_active Expired - Lifetime
- 1998-12-14 SK SK1183-2000A patent/SK11832000A3/en unknown
- 1998-12-14 CA CA002320190A patent/CA2320190C/en not_active Expired - Lifetime
-
2000
- 2000-08-10 NO NO20004029A patent/NO20004029L/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2000123400A (en) | METHOD FOR REMOVING ETHIOLOGICAL FACTOR (FACTORS) OF TRANSMISSIVE SPAN Encephalopathies FROM PROTEIN SOLUTIONS | |
DE69721893D1 (en) | Process for the separation of cells from blood | |
EP1679383A3 (en) | Method and device for purifying nucleid acids | |
CA2200148A1 (en) | Use of structured depth filters for virus removal | |
DE69606960T2 (en) | Adsorbent, process for its preparation and method for the treatment of fruit juice | |
US20070062877A1 (en) | Dialysis device | |
CA2320190A1 (en) | A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions | |
KR950032269A (en) | How to remove virus from protein solution | |
DE3773673D1 (en) | METHOD FOR THE PRODUCTION OF PYROGEN-FREE COLLAGEN GELS, USED FOR CONTACT LENSES. | |
FR2548538A1 (en) | PRODUCTION OF HUMAN INTERFERON AND METHOD FOR DETERMINING THE ABILITY OF THE BLOOD TO PRODUCE INTERFERON | |
Piot et al. | Preparation of decolorized peptides from slaughter-house blood | |
JPS647788B2 (en) | ||
GB2024228A (en) | Process and adsorbent for the isolation in purer form of enzyme(s) from a crude enzyme solution | |
JP3118236B2 (en) | Method for producing angiotensin I converting enzyme inhibitor | |
KR0149793B1 (en) | Purification method of high molecular hydraulic acid | |
CA2208928A1 (en) | Selective stabilization of protein during viral inactivation | |
KR970021091A (en) | Rapid separation and purification of protein from slaughter blood such as cattle and pigs | |
SU1045450A1 (en) | Method of determining coagulation time | |
RU2160111C1 (en) | Method for obtaining high activity raw materials for producing complete soluble thromboplastin | |
SU854978A1 (en) | Method of purifying milk-coagulating enzyme | |
RU2359682C1 (en) | Method of reception of hemin | |
JPH04108341A (en) | Method for improving blood plasma | |
SU1377736A1 (en) | Method of determining insulin in erythrocytes | |
Seelich et al. | Reactivity of fibrinogen crosslinking sites in the absence of thrombin | |
RU96120788A (en) | METHOD FOR PRODUCING CONCENTRATED BLOOD SERUM |